HLS Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12.33	11.72	17.46	21.95	20.72	21.18
Cash & Short-Term Investments	12.33	11.72	17.46	21.95	20.72	21.18
Cash Growth	-30.50%	-32.84%	-20.48%	5.93%	-2.15%	2.75%
Accounts Receivable	8.13	7.86	7.45	10.61	11	11.51
Inventory	7.36	8.14	9.06	9.53	8.9	8.93
Other Current Assets	1.13	1.37	1.43	2	3.75	2.14
Total Current Assets	28.95	29.09	35.4	44.1	44.37	43.75
Net Property, Plant & Equipment	1.17	1.34	1	0.97	1.13	1.57
Other Intangible Assets	99.63	105.63	122.12	162.34	195.02	229.18
Other Long-Term Assets	1.33	1.47	1.39	1.66	1.13	1.4
Total Assets	131.09	137.53	159.9	209.06	241.65	275.91
Accounts Payable	9.93	10.44	8.71	14.11	12.79	10.6
Short-Term Debt	4.72	4.82	5.32	6.88	15.47	13.51
Other Current Liabilities	14.18	10.87	8.52	5.71	2.93	3.57
Total Current Liabilities	28.82	26.12	22.55	26.69	31.19	27.67
Long-Term Debt	40.84	46.68	61.94	84.23	84.58	86.84
Other Long-Term Liabilities	2.86	3.06	4.07	0.44	0.57	0.65
Total Long-Term Liabilities	43.7	49.74	66.02	84.68	85.14	87.5
Total Liabilities	72.52	75.86	88.56	111.36	116.33	115.17
Common Stock	256.34	256.34	260.6	262.13	265.21	265.92
Additional Paid-in Capital	16.39	16.16	15.14	13.87	13.82	11.72
Accumulated Other Comprehensive Income	-7.71	-6.68	-10.21	-2.84	-5.26	2.96
Retained Earnings	-206.45	-204.15	-194.18	-175.46	-148.45	-119.86
Shareholders' Equity	58.57	61.67	71.34	97.7	125.32	160.74
Total Liabilities & Equity	131.09	137.53	159.9	209.06	241.65	275.91
Total Debt	45.55	51.5	67.26	91.11	100.05	100.35
Net Cash (Debt)	-33.23	-39.77	-49.81	-69.16	-79.33	-79.17
Net Cash Per Share	-1.06	-1.26	-1.56	-2.14	-2.45	-2.46
Book Value	58.57	61.67	71.34	97.7	125.32	160.74
Book Value Per Share	1.87	1.96	2.24	3.03	3.86	4.99
Tangible Book Value	-41.06	-43.96	-50.78	-64.65	-69.7	-68.45
Tangible Book Value Per Share	-1.31	-1.39	-1.59	-2.00	-2.15	-2.13